Israel - English - Ministry of Health

abic marketing ltd, israel - vincristine sulfate - solution for injection - vincristine sulfate 1 mg/ml - vincristine - vincristine - vincristine may be used either as sole agent or in combination therapy in the treatment of acute leukemias. malignant lymphomas including hodgkin's disease lymphosarcoma and reticulum cell sarcoma, neuroblastoma, wilm's tumor, rhabdomyosarcoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - colistimethate sodium (equivalent: colistin, qty iu) - injection, powder for - excipient ingredients: - colistin link parental is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. it is particularly indicated when the infection is caused by sensitve strains of pseudomonas aeruginosa. this antibiotic is not indicated for infections due to proteus and neisseria. colistin link parental has proven clinically effective in treatment of infections due to the following gram-negative organisms: enterobacter aerogenes, escherichia coli, klebsiella pneumoniae and pseudomonas aeruginosa. pending results of appropriate bacterialogic cultures and sensitvity tests, colistin link parental may be used to initiate therapy in serious infections that are suspected due to gram-negative organisms.

United States - English - NLM (National Library of Medicine)

hospira, inc. - vincristine sulfate (unii: t5iro3534a) (vincristine - unii:5j49q6b70f) - vincristine sulfate injection is indicated in acute leukemia. vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non–hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and wilms' tumor. patients with the demyelinating form of charcot–marie–tooth syndrome should not be given vincristine sulfate injection. careful attention should be given to those conditions listed under warnings and precautions .

United States - English - NLM (National Library of Medicine)

hospira, inc. - vincristine sulfate (unii: t5iro3534a) (vincristine - unii:5j49q6b70f) - vincristine sulfate injection is indicated in acute leukemia. vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non–hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, and wilms' tumor. patients with the demyelinating form of charcot–marie–tooth syndrome should not be given vincristine sulfate injection. careful attention should be given to those conditions listed under warnings and precautions .

Malta - English - Medicines Authority

hospira uk limited - vincristine sulfate - solution for injection - vincristine sulfate 1 mg - antineoplastic agents

Malta - English - Medicines Authority

hospira uk limited - vincristine sulfate - solution for injection - vincristine sulfate 1 mg - antineoplastic agents

Malta - English - Medicines Authority

pfizer hellas s.a. - vincristine sulfate - solution for injection - vincristine sulfate 1 milligram(s)/millilitre - antineoplastic agents

Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - vincristine sulfate - solution for infusion or injection - vincristine sulfate 1 mg/ml - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; sulfuric acid - vincristine is used primarily in the treatment of acute leukaemia, usually as a component of various chemotherapeutic regimens. it has also been used as part of combination therapy in the treatment of hodgkin's disease, non-hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, wilm's tumour, osteogenic sarcoma, mycosis fungoides, ewing's sarcoma, carcinoma of the uterine cervix, breast cancer, malignant melanoma, oat-cell carcinoma of the lung and gynaecological tumours of childhood. vincristine may be useful in patients with true idiopathic thrombocytopenic purpura resistant to the usual treatment, but not recommended as primary treatment for this disorder

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - vincristine sulfate - solution for injection/infusion - 1 micromole(s) - vinca alkaloids and analogues; vincristine